![Mary Reumuth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mary Reumuth
Keine laufenden Positionen mehr
Vermögen: - $ am 31.05.2026
Profil
Mary E.
Reumuth worked as an Auditor at Ernst & Young LLP.
Served as Manager-External Financial Reporting at Genzyme Corp.
Worked as Finance Director at Verenium Corp.
from 2007 to 2011.
Held the position of Controller at Enobia Pharma, Inc. from 2011 to 2012.
Was Vice President-Finance & Controller at Kala Bio, Inc. from 2014 to 2017.
Served as Independent Director at Olink Holding AB from 2022 to 2024.
Completed undergraduate education at Texas A&M University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
KALA BIO, INC. -.--% | 23.10.2025 | 0 ( -.--% ) | - $ | 31.05.2026 |
Ehemalige bekannte Positionen von Mary Reumuth
| Unternehmen | Position | Ende |
|---|---|---|
| KALA BIO, INC. | Finanzdirektor/CFO | 23.11.2025 |
| OLIK HLDG | Direktor/Vorstandsmitglied | 01.08.2024 |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Comptroller/Controller/Auditor | 01.06.2012 |
| VERENIUM CORP | Finanzdirektor/CFO | 01.03.2011 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | - |
Ausbildung von Mary Reumuth
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
33
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Kala Bio, Inc.
 Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enobia Pharma, Inc.
Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for bone disorders | Health Technology |
Verenium Corp.
 Verenium Corp. BiotechnologyHealth Technology Produces cellulosic ethanol derived from multiple biomass feedstocks | Health Technology |
Olink Holding AB
 Olink Holding AB BiotechnologyHealth Technology Develops proteomics platform | Health Technology |
Wählen Sie MarketScreener 
